+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global DNA Sequencing Products Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797905
The global market value was USD 5.53 billion in 2022, driven by the increasing advancements in sequencing technologies across the globe. The market size is anticipated to grow at a CAGR of 16% during the forecast period of 2023-2031 to achieve a value of USD 21.32 billion by 2031.

DNA Sequencing Products Introduction

DNA sequencing products are used to determine the precise sequence of nucleotides in a given DNA molecule. These products can be used in a variety of applications, such as identifying genetic mutations, analyzing gene expression patterns, and identifying pathogens in clinical samples. DNA sequencing has become increasingly important in both basic research and clinical settings, as it can provide insights into the underlying mechanisms of disease and help guide personalized treatment strategies.

The DNA sequencing products market is driven by factors such as increasing demand for personalized medicine, growing applications of DNA sequencing in clinical diagnostics, and declining costs of sequencing technologies. However, the market also faces challenges such as data management and analysis complexities, ethical concerns, and limited reimbursement policies.

Overall, the DNA sequencing products market is expected to continue to grow in the coming years, driven by advancements in sequencing technologies, increasing applications in research and clinical settings, and the growing trend towards precision medicine.

DNA Sequencing Products Market Scenario

DNA sequencing is the process of determining the sequence of nucleotides in a DNA molecule. DNA sequencing products include instruments, reagents, and software used to perform DNA sequencing. The technology has advanced rapidly in recent years, resulting in significant cost reductions and increased speed and accuracy. This has led to increased use of DNA sequencing in a wide range of applications, including research, clinical diagnostics, and forensics.

The market for DNA sequencing products is highly competitive, with several major players dominating the market. Key factors driving growth in the market include the increasing demand for personalized medicine, the growing need for disease diagnosis and treatment, and the increasing use of DNA sequencing in drug development and clinical trials. Technological advancements such as next-generation sequencing and the development of new sequencing platforms are also expected to drive market growth.

However, factors such as the high cost of sequencing instruments and the lack of skilled professionals are expected to restrain market growth to some extent. In addition, ethical and legal concerns surrounding the use of genetic information may also impact the market. Despite these challenges, the DNA sequencing products market is expected to continue to grow rapidly in the coming years, driven by the increasing demand for genetic information in a wide range of applications.

DNA Sequencing Products Market Segmentations

Market Breakup by Product Type

  • Instruments
  • Consumables
  • Services

Market Breakup by Type

  • Whole genome sequencing
  • Exome sequencing
  • Targeted sequencing
  • Others
  • Polymer
  • Others

Market Breakup by Applications

  • Research Applications
  • Clinical Applications
  • Others

Market Breakup by End User

  • Academic Institutes and Research Centers
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the DNA Sequencing Products Market

Key trends in the DNA sequencing products market include:

  • Increasing adoption of next-generation sequencing (NGS) technologies for research and clinical applications due to their high accuracy, speed, and affordability compared to traditional sequencing methods
  • Growing demand for personalized medicine and targeted therapy, which require comprehensive genomic analysis to identify mutations and genetic variations associated with specific diseases
  • Emergence of new applications of DNA sequencing such as metagenomics, epigenomics, and transcriptomics, which are enabling researchers to study complex biological systems and processes in unprecedented detail
  • Increasing focus on the development of portable, easy-to-use, and cost-effective sequencing devices that can be used in resource-limited settings or in the field
  • Rising investments in genomics research and development by government organizations, academic institutions, and private companies, which are driving innovation and new product development in the market

DNA Sequencing Products: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Illumina Inc
  • Thermo Fischer Scientific Inc
  • Oxford Nanopore Technologies plc
  • Agilent Technologies, Inc
  • BGI
  • PerkinElmer Inc
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • Takara Bio Inc
  • GENEWIZ, Inc
  • Hamilton Company
  • Macrogen Inc
  • Zymo Research Corporation
  • Tecan Trading AG

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global DNA Sequencing Products Market Overview
3.1 Global DNA Sequencing Products Market Historical Value (2016-2022)
3.2 Global DNA Sequencing Products Market Forecast Value (2023-2031)
4 Global DNA Sequencing Products Market Landscape
4.1 Global DNA Sequencing Products Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global DNA Sequencing Products Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global DNA Sequencing Products Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global DNA Sequencing Products Market Segmentation
6.1 Global DNA Sequencing Products Market by Product Type
6.1.1 Market Overview
6.1.2 Instruments
6.1.3 Consumables
6.1.4 Services
6.2 Global DNA Sequencing Products Market by Technology
6.2.1 Market Overview
6.2.2 Sanger Sequencing
6.2.3 Next-Generation Sequencing Whole Genome Sequencing (WGS) Whole Exome Sequencing (WES) Targeted Sequencing & Resequencing
6.2.4 Others
6.3 Global DNA Sequencing Products Market by Applications
6.3.1 Market Overview
6.3.2 Biomarkers
6.3.3 Diagnostics
6.3.4 Reproductive Health
6.3.5 Forensics
6.3.6 Personalized Medicine
6.3.7 Others
6.4 Global DNA Sequencing Products Market by End User
6.4.1 Market Overview
6.4.2 Academic Institutes and Research Centers
6.4.3 Hospitals and Clinics
6.4.4 Pharmaceutical and Biotechnology Companies
6.4.5 Others
6.5 Global DNA Sequencing Products Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America DNA Sequencing Products Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe DNA Sequencing Products Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific DNA Sequencing Products Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America DNA Sequencing Products Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa DNA Sequencing Products Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Illumina Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Thermo Fischer Scientific Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Oxford Nanopore Technologies plc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Agilent Technologies, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 BGI
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 PerkinElmer Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Eurofins Scientific
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 F. Hoffmann-La Roche Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Takara Bio Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 GENEWIZ, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Hamilton Company
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Macrogen Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Zymo Research Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
18 Global DNA Sequencing Products Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Illumina Inc.
  • Thermo Fischer Scientific Inc.
  • Oxford Nanopore Technologies plc.
  • Agilent Technologies, Inc.
  • Bgi
  • Perkinelmer Inc.
  • Qiagen
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Takara Bio Inc.
  • Genewiz, Inc.
  • Hamilton Company
  • Macrogen Inc.
  • Zymo Research Corporation



Table Information